Is Argininosuccinic Aciduria hereditary?

Argininosuccinic Aciduria (ASA) is a hereditary metabolic disorder. It is caused by a deficiency of the enzyme argininosuccinate lyase, which is responsible for breaking down argininosuccinic acid in the body. This enzyme deficiency is inherited in an autosomal recessive manner, meaning that both parents must carry a copy of the mutated gene for their child to be affected.

When both parents are carriers of the mutated gene, there is a 25% chance with each pregnancy that their child will inherit two copies of the mutated gene and develop ASA. Individuals who inherit two copies of the mutated gene will have a complete deficiency of argininosuccinate lyase and will experience a buildup of argininosuccinic acid in their body.

Argininosuccinic Aciduria can be diagnosed through genetic testing. If there is a family history of ASA or if a child presents with symptoms such as poor feeding, vomiting, seizures, developmental delay, or liver dysfunction, genetic testing can be performed to confirm the diagnosis.

Treatment for Argininosuccinic Aciduria involves a strict low-protein diet and medication. The goal of treatment is to reduce the levels of argininosuccinic acid in the body and prevent the buildup of toxic substances. A low-protein diet, supplemented with essential amino acids, is necessary to limit the production of argininosuccinic acid. Medications such as nitrogen scavengers may also be prescribed to help remove excess nitrogen from the body.

Argininosuccinic Aciduria is a lifelong condition that requires ongoing management and monitoring. Regular follow-up with a metabolic specialist is essential to ensure that the treatment plan is effective and to monitor for any potential complications. With early diagnosis and appropriate management, individuals with ASA can lead relatively normal lives and prevent the occurrence of metabolic crises.